American Financial Group’s Cognition Therapeutics CGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $63.5K | Hold |
205,000
| – | – | 0.02% | 61 |
|
|
2025
Q1 | $86.3K | Hold |
205,000
| – | – | 0.04% | 59 |
|
|
2024
Q4 | $144K | Hold |
205,000
| – | – | 0.07% | 59 |
|
|
2024
Q3 | $96K | Hold |
205,000
| – | – | 0.04% | 64 |
|
|
2024
Q2 | $340K | Hold |
205,000
| – | – | 0.15% | 56 |
|
|
2024
Q1 | $373K | Hold |
205,000
| – | – | 0.14% | 59 |
|
|
2023
Q4 | $379K | Hold |
205,000
| – | – | 0.14% | 64 |
|
|
2023
Q3 | $295K | Hold |
205,000
| – | – | 0.1% | 72 |
|
|
2023
Q2 | $375K | Hold |
205,000
| – | – | 0.12% | 73 |
|
|
2023
Q1 | $406K | Hold |
205,000
| – | – | 0.13% | 73 |
|
|
2022
Q4 | $430K | Hold |
205,000
| – | – | 0.14% | 75 |
|
|
2022
Q3 | $389K | Hold |
205,000
| – | – | 0.13% | 75 |
|
|
2022
Q2 | $432K | Hold |
205,000
| – | – | 0.15% | 73 |
|
|
2022
Q1 | $564K | Hold |
205,000
| – | – | 0.17% | 68 |
|
|
2021
Q4 | $1.3M | Buy |
+205,000
| New | +$1.3M | 0.35% | 52 |
|